PHARMING GROUP (PHARM.AS) Financials
PHARM.AS Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | 418.7 million | 220.8 million |
| 2023-09-30 | 412.3 million | 214.0 million |
| 2023-06-30 | 395.3 million | 211.0 million |
| 2023-03-31 | 388.1 million | 205.2 million |
PHARM.AS Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | 10.2 million | 3.0 million |
| 2023-09-30 | 3.2 million | 1.9 million |
| 2023-06-30 | -9.6 million | 2.2 million |
| 2023-03-31 | -21.1 million | 1.4 million |
PHARM.AS Net Income
Graph available only for supporters. Become a supporter to see it.
| Date | Net Income |
|---|---|
| 2023-12-31 | -1.8 million |
| 2023-09-30 | 3.1 million |
| 2023-06-30 | 3.1 million |
| 2023-03-31 | -15.3 million |
PHARM.AS Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | 193.1 million | - | 30.0 million |
| 2023-09-30 | 186.6 million | - | 30.7 million |
| 2023-06-30 | 176.9 million | - | 31.4 million |
| 2023-03-31 | 169.5 million | - | 32.1 million |
PHARM.AS Shares Outstanding
PHARM.AS Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | 299423 | 10.5 million | 44.2 million | 71.8 million |
| 2023-09-30 | 138856 | 19.6 million | 10.3 million | 23.7 million |
| 2023-06-30 | 709073 | 19.2 million | 10.1 million | 31.2 million |
| 2023-03-31 | 197246 | 14.3 million | 9.2 million | 24.9 million |
PHARM.AS Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | 73.5 million | 6.4 million |
| 2023-09-30 | 63.0 million | 7.8 million |
| 2023-06-30 | 50.5 million | 5.3 million |
| 2023-03-31 | 39.0 million | 3.7 million |
PHARM.AS
Price: €0.83
52 week price:
Earnings Per Share: -0.01 EUR
P/E Ratio: -35.27
Exchange: AMS
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 572.4 million